Myofibroblasts are a subset of activated fibroblasts, characterized by expression of α-smooth muscle actin (α-SMA), which are the principal cell type responsible for excessive collagen deposition during renal fibrosis that is regarded as a common pathway leading to end-stage renal failure in chronic renal diseases. [1] [2] [3] [4] However, the origin of myofibroblasts in the fibrosing kidney has remained an issue of debate. [5] [6] [7] Studies in animal disease models and in cell culture systems have identified several possible origins for the myofibroblasts present in active renal fibrosis, including epithelialmesenchymal transition (EMT), [8] [9] [10] endothelial-mesenchymal transition, 11, 12 local proliferation of resident fibroblasts or pericytes 13, 14 and circulating fibrocytes. 15, 16 We have recently described one further potential mechanism: macrophage to myofibroblast transition (MMT). 17 Evidence for this MMT process is based upon adoptive transfer and bone marrow chimera studies in the mouse model of unilateral ureteric obstruction (UUO) and cell culture studies. 17 It is proposed that bone marrow-derived macrophages can enter the injured kidney and then transdifferentiate into collagen-producing α-SMA + myofibroblasts via TGF-β/ Smad3 signaling. 17 However, several important issues remain to be addressed: (i) does MMT occur in human fibrotic kidney disease; (ii) can MMT be confirmed by lineage tracing studies, and (iii) can lineage depletion of macrophages prevent the MMT response and suppress renal fibrosis? This study addressed these questions by investigating the MMT process in human kidney disease and by using the LysM-Cre myeloid promoter to trace macrophages undergoing MMT, and to determine whether depleting cells of this lineage can suppress renal fibrosis.
Results
MMT in human kidney fibrosis. The term 'macrophage to myofibroblast transition' (MMT) describes the overall process by which a macrophage transitions into a myofibroblast, while the term 'MMT cells' refers to individual cells that are in the process of transition with an intermediate phenotype in which they express markers of both lineages. To identify MMT cells in human kidney disease, we sought to detect cells that express both macrophage (CD68) and myofibroblast (α-SMA) markers. Biopsy tissues were staged as acute (inflammation with little fibrosis), active (inflammation with active fibrosis) or sclerotic (advanced sclerosis with little inflammation) lesions. In patients with crescentic glomerulonephritis, numerous CD68 + macrophages were identified in acute inflammatory lesions such as cellular crescents, but few CD68 + α-SMA + cells were evident (Figures 1a and d) . In contrast, a substantial number of CD68 + α-SMA + cells were present in biopsies featuring active fibrosis in fibrocellular crescents and progressive interstitial fibrosis in patients with IgA nephropathy (Figures 1b-d) , indicating that MMT accounts for a substantial proportion of the myofibroblast population in active renal fibrosis. Biopsies with advanced sclerosis showed an overall increase in the number of α-SMA + myofibroblasts and a reduction in both total CD68 + macrophages and in CD68 + α-SMA + MMT cells (Figure 1d ). There was a significant correlation between the number of MMT cells and the total α-SMA + myofibroblast population in acute and active fibrosis (Figure 1e ). In contrast, MMT cells were not detected in normal human kidney or minimal change disease (Figures 1f and g ).
We next examined whether MMT cells exhibited an M2 phenotype based on the well-characterized M2 marker, CD206. Three-color confocal microscopy was performed in six cases with active fibrosis. The majority of CD68 + macrophages in these cases with active fibrosis co-expressed the CD206 marker. Furthermore, the majority of CD68 + α-SMA + cells expressed CD206, suggesting that it is predominantly M2-type macrophages that undergo MMT in human renal fibrosis ( Figure 2 ).
Macrophage lineage tracing identifies MMT in experimental renal fibrosis. We sought to establish the MMT process using lineage tracing. We used LysM-Cre/Rosa26-tdTomato mice in which myeloid cells and their progeny permanently express the Rosa26-Tomato (red fluorescence) reporter. Confocal microscopy and flow cytometry analysis revealed that almost all F4/80 + macrophages co-expressed Tomato in normal and sham-operated kidneys of LysM-Cre/ Rosa26-tdTomato mice (Figures 3a and b) . Similarly, Tomato expression in other organs (liver, heart, peritoneum) was also largely restricted to resident macrophages and was clearly separated from α-SMA staining of vascular cells (Supplementary Figure S1) .
Examination of LysM-Cre/Rosa26-tdTomato mice in the UUO model by confocal microscopy showed co-expression of Tomato and F4/80 in most cells (Tomato Figures S2 and S3) . Flow cytometric analysis of the obstructed kidney showed that more than 90% of F4/80+ macrophages co-expressed Tomato (Figure 3b ). In addition, approximately 22% of Tomato + cells in the obstructed kidney expressed α-SMA and these Tomato 
Discussion
Our recent study identified that bone marrow-derived macrophages can undergo myofibroblast transition in vitro and in experimental renal fibrosis via a process of MMT driven by the TGF-β/Smad3 signaling pathway. 17 The current studies provide extensive new data to support this postulate based on: (i) identification of CD68 + α-SMA + myofibroblasts in areas of active fibrosis in patients with kidney disease; (ii) establishing that MMT cells have a predominant M2 phenotype in human kidney fibrosis; (iii) the use of myeloid lineage tracing to validate that macrophages can undergo conversion into a collagen I-producing myofibroblast in experimental renal fibrosis; and (iv) depletion of myeloid lineage cells prevented the appearance of MMT cells and substantially reduced myofibroblast accumulation and collagen deposition in experimental renal fibrosis.
Although myofibroblast differentiation and activation are recognized as central events in the pathogenesis of renal fibrosis, the origin of this myofibroblast population remains controversial. 7, 18 A 1995 study identifying expression of fibroblast specific protein-1 (FSP-1) in tubular epithelial cells led to the concept of EMT as a source of myofibroblasts in renal fibrosis, 19 although this hypothesis has been challenged in recent years due to findings from lineage tracing studies and a lack of persuasive clinical evidence. 5-7 Therefore, we considered it is important to validate our previous study of the MMT process in renal fibrosis with both human data and lineage tracing data. The identification of significant numbers of CD68 + α-SMA + MMT cells in active fibrotic lesions in human disease, but their absence in acute inflammation and advanced sclerosis, provides strong support for the importance of MMT in the pathogenesis of renal fibrosis in human chronic kidney diseases and provides clinical relevance to the findings in the animal studies. The detection of MMT cells in rapidly progressive forms of glomerulonephritis is not surprising given the prominent macrophage infiltrates seen in these conditions, but MMT cells detected in patients with IgA nephropathy reveal MMT as a common process during the development of progressive renal fibrosis. Thus, MMT may be an important mechanism in the progression from acute macrophage-rich inflammation towards active fibrosis. The low percentage of α-SMA + myofibroblasts co-expressing macrophage markers in advanced sclerotic lesions presumably reflects a completion of this transition process.
The lineage tracing studies using the well-characterized LysM-Cre promoter to drive Tomato expression in myeloid cells provided a robust demonstration of the MMT process using both confocal microscopy and flow cytometry in experimental renal fibrosis. These findings extend our previous studies using ex vivo dye labeling of isolated macrophage populations and GFP+ bone marrow chimeric mice. 17 In addition, while the approach of flow cytometry to measure collagen I production by fibroblasts has been questioned recently, 20 the demonstration that Tomato + cells produced collagen I in the UUO model is consistent with our previous study in which CD11b + macrophages infiltrating into the obstructed kidney markedly up-regulate collagen I and III mRNA levels. It is noteworthy that Tomato + F4/80 + α-SMA + MMT cells account for more than 60% of the total number of α-SMA + cells, demonstrating the potential importance of macrophage-derived myofibroblasts.
In addition to using lineage tracing to identify a macrophage origin for a substantial proportion of collagen-producing myofibroblasts in renal fibrosis, we also performed the reciprocal experiment in which the functional requirement of myeloid-derived myofibroblasts in the development of renal fibrosis was demonstrated by depleting cells of this lineage in LysM-Cre/DTR mice. Although a reduction in myofibroblast accumulation and collagen deposition has been described previously with different macrophage depletion strategies in the UUO model, 21, 22 the current studies provide the critical missing link by establishing that macrophages exert a profibrotic effect by directly transforming into myofibroblasts via the MMT process.
The presence of MMT may reflect disease activity and fibrotic progression in human kidney disease and it may also explain the notion that the density and heterogeneity of the macrophage infiltrate determine the fate of renal inflammation and fibrosis. 23, 24 It is of note that infiltration of M2 macrophages positively correlates with the progression of renal fibrosis in human kidney diseases. 25, 26 In this setting, the present study identified that the large majority of MMT cells in human kidney fibrosis express the M2 marker, CD206. This confirms the of CD206 expression by MMT cells in the UUO model, confirms our previous studies indicating that M2 macrophages had a greater capacity to undergo MMT compared with M1 macrophages 17 and gives support to other studies demonstrating that bone marrow-derived M2 macrophages are highly proliferative and pro-fibrotic. 27, 28 Based upon the present findings and our recently published work, we propose a new paradigm in renal fibrosis in which infiltrating bone marrow-derived blood monocytes can differentiate into M1 pro-inflammatory macrophages and cause injury to the kidney. Consequently, a repair process driven by TGF-β1 induces a switch of M1 macrophages towards an M2 pro-fibrotic phenotype. [29] [30] [31] [32] [33] A key component in this repair process is TGF-β1/Smad3-driven MMT, 17, 34, 35 which induces the transition of M2 macrophages into collagen-producing α-SMA + myofibroblasts which contribute to the excessive deposition of extracellular matrix occurring during renal fibrosis.
The results of this study are consistent with recent experiments identifying a significant contribution of bone marrowderived fibroblasts in mouse models of renal fibrosis. 36 Indeed, it may be the case that these bone marrow-derived fibroblasts are the same population identified in our lineage tracing studies; however, this remains to be established. In addition, recent studies have shown a role for adiponectin/AMPK and JAK3/STAT6 signaling pathways in the development of experimental renal fibrosis and in collagen production by cultured mouse monocytes, 37, 38 providing new potential therapeutic targets in addition to TGF-β/Smad3 signaling.
In conclusion, we have shown that macrophages can transdifferentiate into collagen-producing α-SMA + myofibroblasts during renal fibrosis in human and experimental kidney disease. Targeting the MMT process may represent a novel therapeutic approach for the treatment of fibrotic renal diseases. Animals and animal models. LysM-Cre mice (stock number 004781) and Cre-dependent tdTomato reporter transgene mice (stock number 007914, referred to as Rosa26-tdTomato mice), both on the C57/Bl6 background, were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). The mouse strains were intercrossed to generate LysM-Cre/Rosa26-tdTomato mice. Groups of eight LysMCre/Rosa26-tdTomato mice and their littermate control mice underwent UUO or sham surgery and were killed 7 days later as previously described. 39 In the macrophage depletion study, macrophages were conditionally deleted from LysM-Cre/DTR mice by intraperitoneal injection of diphtheria toxin as previously described. 40 UUO nephropathy was performed by ligation of the left ureter and mice were killed 7 days later. Groups of 6-8 mice of both genders, aged 8-10 weeks were studied. The experimental protocols were approved by the Institutional Animal Experimentation Ethics Committee of The Chinese University of Hong Kong.
Immunofluorescence and confocal image analysis. Immunofluorescence and confocal microscopy were performed on frozen sections. Macrophages were labeled with rat anti-mouse F4/80 (Serotec Ltd, Oxford, UK) or FITC-conjugated mouse anti-human CD68 (DAKO, Carpinteria, CA, USA), while Flow cytometric analysis. Single cells were isolated from both normal and fibrotic kidneys using enzyme-digestion and analyzed by flow cytometry as previously described. 17 After permeabilization with Fixation/Permeabilization buffer kit (eBioscience, San Diego, CA, USA), cells were incubated with FITC-conjugated rat anti-mouse F4/80 (eBioscience) followed by Cy5-conjugated goat anti-rat IgG (Millpore), PE-conjugated anti-α-SMA (R&D, Minneapolis, MN, USA), FITC-labeled rat anti-mouse CD206 (Serotec). Collagen I was stained with rabbit anti-mouse collagen I (Millpore) followed by the Cy5-labeled goat anti-rabbit IgG (Invitrogen). Cells stained with isotype-matched irrelevant control antibodies and unstained cells were used as negative controls. Cells were detected by a FACS Calibur flow cytometer (BD Biosciences, San Jose, CA, USA) and analyzed by Cellquest software (BD Biosciences).
Immunohistochemistry. Immunostaining was performed on 3-μm paraffin sections using a microwave-based antigen retrieval technique. 41 The antibodies utilized in the present study included collagen I (Southern Biotech), α-SMA (Sigma) and F4/80 (Serotec).
Real-time PCR and western blot analysis. Total RNA was isolated from kidney tissue by using the RNeasy Isolation Kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's instructions. Collagen I and α-SMA were quantitatively analyzed at the mRNA levels by real-time PCR and at the protein levels by western blot analysis as previously described. 
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